GENINUS Inc. (KOSDAQ:389030)
South Korea
· Delayed Price · Currency is KRW 5,180.00
-280.00 (-5.13%)
At close: Apr 28, 2026
GENINUS Market Cap
GENINUS has a market cap or net worth of 173.20 billion as of April 28, 2026. Its market cap has increased by 306.97% in one year.
Market Cap
173.20B
Enterprise Value
168.71B
Revenue
10.48B
Ranking
n/a
PE Ratio
n/a
Stock Price
5,180.00
Market Cap Chart
Since November 8, 2021, GENINUS's market cap has increased from 145.65B to 173.20B, an increase of 18.91%. That is a compound annual growth rate of 3.95%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 28, 2026 | 173.20B | 48.37% |
| Dec 30, 2025 | 116.73B | 154.55% |
| Dec 30, 2024 | 45.86B | -47.60% |
| Dec 28, 2023 | 87.52B | 25.13% |
| Dec 29, 2022 | 69.94B | -49.53% |
| Dec 30, 2021 | 138.58B | -4.85% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Inventera | 183.66B |
| Cytogen | 116.50B |
| HLB Panagene | 99.35B |
| Green Cross Medical Science | 84.90B |
| 3billion | 442.44B |
| Dx & Vx | 467.54B |
| Protia | 63.36B |
| Seoulin Bioscience | 57.11B |